Catalyst Pharmaceuticals (CPRX) Capital Expenditures Growth (1y) (2012 - 2025)
Catalyst Pharmaceuticals (CPRX) Capital Expenditures Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 143.40% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63.64% |
| Jun 30, 2025 | 160.00% |
| Dec 31, 2024 | -5.38% |
| Sep 30, 2024 | 304.69% |
| Mar 31, 2024 | 168.92% |
| Dec 31, 2019 | -100.65% |
| Jun 30, 2019 | 15.08% |
| Sep 30, 2016 | -99.99% |
| Sep 30, 2015 | 9.96% |
| Jun 30, 2015 | -91.31% |
| Mar 31, 2015 | -54.29% |
| Jun 30, 2014 | 1,300,300.00% |
| Mar 31, 2014 | 83.46% |
| Jun 30, 2013 | -100.05% |
| Mar 31, 2013 | 89.38% |
| Dec 31, 2012 | 2,400.00% |